Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

BUY
$0.34 - $0.56 $0 - $0
0 New
0 $0
Q1 2023

May 15, 2023

BUY
$0.32 - $1.54 $0 - $0
0 New
0 $0
Q4 2022

Jan 30, 2023

BUY
$0.26 - $0.56 $0 - $0
0 New
0 $0
Q3 2022

Nov 15, 2022

BUY
$0.16 - $1.0 $0 - $0
0 New
0 $0
Q2 2022

Aug 09, 2022

BUY
N/A
0 New
0 $0
Q1 2022

May 09, 2022

BUY
N/A
0 New
0 $0
Q4 2021

Feb 07, 2022

BUY
N/A
0 New
0 $0
Q3 2021

Nov 09, 2021

BUY
N/A
0 New
0 $0

About SeqLL, Inc.


  • Ticker SQL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 11,886,400
  • Market Cap $47.5M
  • Description
  • SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. The company designs, develops, and manufactures genetic analysis technologies. It offers true single molecule sequencing (tSMS) platform, which offers a single molecule solution for DNA and RNA sequencing. The company has a collaboration agreement wit...
More about SQL
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.